News Related to Glucagon-Like Peptide-1 (GLP-1)

Related coverage linked through entity extraction aliases.

GLP-1 Drugs Discovered in Fish Research Now Treat Multiple Conditions

Apr 07, 2026

GLP-1 drugs discovered accidentally in anglerfish research now treat conditions beyond diabetes including kidney disease, sleep apnea, and addiction. The global diabetes therapeutics market is projected to reach $241.5 billion by 2030, growing at 12.4% annually.

FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Weight Loss Products

Feb 13, 2026

The FDA announced plans to restrict non-FDA-approved compounded GLP-1 drugs mass-marketed as alternatives to approved weight loss medications, citing safety concerns and misleading advertising practices.